ACS CAN Comments to FDA on Proposed Rule: Clarification of When Products Made or Derived from Tobacco Are Regulated as Drugs, Devices, or Combination Products

December 30, 2015

The American Cancer Society Cancer Action Network provided comments to the Food and Drug Administration on the proposed clarification of when products made or derived from tobacco are to be regulated as drugs, devices, or combination products under the authority of the Center for Drug Evaluation and Research or as a tobacco product under the authority of the Center for Tobacco Products.